{{Infobox drug
| drug_name         =
| INN               =
| type              =<!-- empty -->
| IUPAC_name        = 4-[2-(''tert''-Butylamino)-1-hydroxyethyl]benzene-1,2-diol
| image             = Colterol.svg
| alt               = 
| caption           =
<!-- Clinical data -->
| pronounce         =
| tradename         = 
| Drugs.com         = 
| MedlinePlus       = 
| pregnancy_AU      = <!-- A/B1/B2/B3/C/D/X -->
| pregnancy_AU_comment = 
| pregnancy_US      = <!-- A/B/C/D/X/N -->
| pregnancy_category= 
| routes_of_administration = 
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_AU_comment =
| legal_BR =  <!-- OTC, A1, A2, A3, B1, B2, C1, C2, C3, C4, C5, D1, D2, E, F-->
| legal_BR_comment =
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_DE = <!-- Anlage I, II, III -->
| legal_NZ = <!-- Class A, B, C -->
| legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM / Class A, B, C -->
| legal_US = <!-- OTC/Rx-only/Schedule I, II, III, IV, V -->
| legal_UN = <!-- N I, II, III, IV / P I, II, III, IV-->
| legal_status      = <!-- Free text -->
<!-- Pharmacokinetic data -->
| bioavailability   = 
| protein_bound     = 
| metabolism        = 
| metabolites       =
| onset             = 
| elimination_half-life = 
| duration_of_action =
| excretion         = 
<!-- Identifiers -->
| CAS_number        = 18866-78-9
| class             = 
| ATCvet            = 
| ATC_prefix        = <!-- 'none' if uncategorised -->
| ATC_suffix        = 
| PubChem           = 25104
| ChemSpiderID      = 23451
| DrugBank          = 
| synonyms          = ''N''-''tert''-Butylarterenol; ''N''-''tert''-Butylnoradrenaline
<!-- Chemical and physical data -->
| C=12|H=19|N=1|O=3
| StdInChI=1S/C12H19NO3/c1-12(2,3)13-7-11(16)8-4-5-9(14)10(15)6-8/h4-6,11,13-16H,7H2,1-3H3
| StdInChIKey=PHSMOUBHYUFTDM-UHFFFAOYSA-N
| smiles = CC(C)(C)NCC(C1=CC(=C(C=C1)O)O)O
}}

'''Colterol''' is a short-acting [[Beta2-adrenergic agonist|β2-adrenoreceptor agonist]].   [[Bitolterol]], a [[prodrug]] for colterol,<ref>{{cite journal|last1=Walker|first1=Susannah B.|last2=Kradjan|first2=Wayne A.|last3=Bierman|first3=C. Warren|title=Bitolterol Mesylate: A Beta-adrenergic Agent; Chemistry, Pharmacokinetics, Pharmacodynamics, Adverse Effects and Clinical Efficacy in Asthma|journal=Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy|date=6 May 1985|volume=5|issue=3|pages=127–137|doi=10.1002/j.1875-9114.1985.tb03410.x|pmid=3895171}}</ref> is used in the management of [[bronchospasm]] in [[asthma]] and [[chronic obstructive pulmonary disease]] (COPD).

==References==
{{reflist}}


{{Adrenergic receptor modulators}}

[[Category:Beta2-adrenergic agonists]]